Telaprevir



Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis C 80.7%
Product Used For Unknown Indication 5.4%
Chronic Hepatitis C 4.5%
Diabetes Mellitus 1.7%
Hypertension 1.1%
Depression 0.9%
Hiv Infection 0.9%
Anaemia 0.8%
Prophylaxis 0.6%
Pruritus 0.5%
Drug Dependence 0.4%
Oedema 0.4%
Pain 0.4%
Cardiac Failure 0.3%
Hypothyroidism 0.3%
Ascites 0.2%
Hepatic Steatosis 0.2%
Osteoporosis 0.2%
Urinary Tract Infection 0.2%
Anxiety 0.2%
Rash 33.7%
Anaemia 11.6%
Vomiting 6.2%
Fatigue 4.7%
Nausea 4.3%
Thrombocytopenia 4.3%
Pyrexia 3.6%
Weight Decreased 3.3%
Pruritus 2.9%
Skin Reaction 2.9%
Urticaria 2.9%
White Blood Cell Count Decreased 2.9%
Rash Generalised 2.5%
Rash Pruritic 2.5%
Drug Rash With Eosinophilia And Systemic Symptoms 2.2%
Proctalgia 2.2%
Dermatitis Exfoliative 1.8%
Malaise 1.8%
Neutropenia 1.8%
Off Label Use 1.8%
Secondary
Hepatitis C 68.6%
Chronic Hepatitis C 15.6%
Product Used For Unknown Indication 4.5%
Hypertension 2.3%
Prophylaxis 1.5%
Hiv Infection 0.9%
Diabetes Mellitus 0.8%
Depression 0.7%
Hepatic Cirrhosis 0.6%
Pain 0.6%
Rash 0.5%
Type 2 Diabetes Mellitus 0.5%
Anaemia 0.4%
Pruritus 0.4%
Hepatitis C Virus Test Positive 0.4%
Insomnia 0.3%
Nausea 0.3%
Pyrexia 0.3%
Anxiety 0.3%
Chronic Obstructive Pulmonary Disease 0.3%
Rash 16.9%
Vomiting 12.6%
Weight Decreased 8.2%
White Blood Cell Count Decreased 8.2%
Anaemia 7.3%
Nausea 5.4%
Pyrexia 5.2%
Thrombocytopenia 4.8%
Pruritus 4.7%
Drug Ineffective 3.3%
Renal Impairment 2.9%
Suicidal Ideation 2.6%
Syncope 2.5%
Rectal Haemorrhage 2.4%
Transfusion 2.4%
Pancytopenia 2.3%
Tremor 2.3%
Drug Reaction With Eosinophilia And Systemic Symptoms 2.1%
Malaise 2.1%
Decreased Appetite 2.0%
Concomitant
Hepatitis C 76.9%
Product Used For Unknown Indication 4.5%
Hiv Infection 2.5%
Chronic Hepatitis C 2.4%
Prophylaxis 2.0%
Hypertension 1.7%
Depression 1.3%
Anaemia 1.2%
Insomnia 1.1%
Nausea 0.9%
Blood Potassium Decreased 0.8%
Diabetes Mellitus 0.8%
Hyperuricaemia 0.8%
Constipation 0.7%
Rheumatoid Arthritis 0.5%
Rhinitis Allergic 0.5%
Chronic Obstructive Pulmonary Disease 0.4%
Inflammation 0.4%
Osteoporosis 0.4%
Anxiety 0.3%
Rash 16.4%
Vomiting 12.7%
White Blood Cell Count Decreased 8.2%
Weight Decreased 6.7%
Pain 6.0%
Pruritus 5.2%
Drug Ineffective 4.5%
Death 3.7%
Pyrexia 3.7%
Renal Failure 3.7%
Somnolence 3.7%
Anaemia 3.0%
Injection Site Erythema 3.0%
Nausea 3.0%
No Therapeutic Response 3.0%
Pyelonephritis Acute 3.0%
Visual Impairment 3.0%
Weight Increased 3.0%
Haemorrhoids 2.2%
Hepatitis C 2.2%
Interacting
Chronic Hepatitis C 27.0%
Hepatitis C 23.0%
Product Used For Unknown Indication 17.6%
Hypertension 9.5%
Pulmonary Arterial Hypertension 5.4%
Liver Transplant 4.1%
Antiretroviral Therapy 2.7%
Convulsion 2.7%
Pain 2.7%
Rash 2.7%
Rash Macular 2.7%
Renal Impairment 30.4%
Drug Interaction 26.1%
Confusional State 8.7%
Thrombocytopenia 8.7%
Drug Level Increased 4.3%
Hepatitis C 4.3%
Immunosuppressant Drug Level Increased 4.3%
Malaise 4.3%
Proctalgia 4.3%
Weight Decreased 4.3%